Further investigation revealed that CUL2 enhanced the sensitivity of GC cells to cisplatin through miR-142-3p/ROCK2-mediated autophagy activation (128), since ROCK2 inhibition was associated with autophagy induction (129, 130). The gene discussed is CUL2; the disease is gastric cancer.